BROWN RYAN EDWARD (SVP, General Counsel) sold 5.9% of their position (2K shares) of SAREPTA THERAPEUTICS, INC. on the open market
Open‑market sale worth $250.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/5/2024ACC: 0000950170-24-026609
Officer· SVP, General Counsel
Since Feb 2021
-8.77K
Net shares
Net seller
$284.6K
Total sold
1
Open market trades
0B · 1S
4
Total transactions
6K acquired · 14.77K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−269.00
Price / share
$126.19
Trade value
$33.95K
% of position
1.0%
3/1/2024
28.10K→27.83K
Common Stock
Direct
Shares
+6K
Price / share
—
Trade value
—
% of position
21.6%
3/1/2024
27.83K→33.83K
Common Stock
Direct
Shares
−2K
Price / share
$125.34
Trade value
$250.68K
% of position
5.9%
3/1/2024
33.83K→31.83K
Total
Net shares
+3.73K
Net value
-$284.63K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2024 | F · Tax Withholding | −269.00 | $126.19 | $33.95K | 1.0% | 28.10K | 27.83K |
| Common Stock Direct | 3/1/2024 | A · Award | +6K | — | — | 21.6% | 27.83K | 33.83K |
| Common Stock Direct | 3/1/2024 | S · Sale | −2K | $125.34 | $250.68K | 5.9% | 33.83K | 31.83K |
| Total | +3.73K | -$284.63K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
12.50K shares
Shares
−12.50K
Strike price
128.67
Held after
12.50K
Exercisable
—
3/1/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock12.50K shares | 3/1/2024 | A · Award | −12.50K | 128.67 | — | 12.50K |